- Home
- News
- Screening Matters, Issue 44, February 2014
- Management of women who have had a smear or colposcopy and treatment overseas
News
- Screening Matters Newsletter
- April 2019
- April 2018
- December 2017
- August 2017
- April 2017
- December 2016
- October 2016
- March 2016
- November 2015
- August 2015
- June 2015
- April 2015
- February 2015
- December 2014
- October 2014
- August 2014
- June 2014
- April 2014
- February 2014
- December 2013
- October 2013
- August 2013
- June 2013
- April 2013
- February 2013
Screening Matters
The National Screening Unit newsletter
In this issue:
- Collaboration achieving results for Newborn Metabolic Screening Programme
- BreastScreen Aotearoa now fully digital
- Book-your-own online appointment system proving popular with colposcopy patients
- Language Line interpreter service helping with informed consent
- Management of women who have had a smear or colposcopy and treatment overseas
- HPV immunisation history: why is this important?
- Updated National Policy and Quality Standards for BreastScreen Aotearoa available
- NCSP Register Central Team update
Management of women who have had a smear or colposcopy and treatment overseas
Overseas clinical histories and results must be reported to laboratories on the laboratory request form submitted with the cervical smear. Based on the history provided, the smear taker may decide, in consultation with the woman, to refer her directly to colposcopy without waiting for a New Zealand laboratory result. However, in doing so the smear taker must provide clear reasons and document the overseas results (where obtainable) on the colposcopy referral form.
New Zealand laboratories report results (cytology, HPV and histology) electronically to the National Cervical Screening Programme (NCSP) Register. Other results (from overseas) and relevant clinical information that smear takers hold are held in the Register’s medical notes for that woman, only if reported to the Programme.
Where a smear taker disagrees with a recall interval recommended by the Programme, (possibly due to overseas results not held by the Programme) the smear taker should notify the NCSP of the clinical history obtained from the woman and include her NHI number and date of birth for identification purposes. This will help to avoid inappropriate follow up letters, based on New Zealand recommendation codes automatically generated by the Register, being sent to the woman.
It is important to recognise that the smear taker is responsible for the ongoing clinical management of a woman who has had a cervical smear in New Zealand (NCSP Policies and Standards, section 4, Providing a Smear taking Service). The laboratory recommendation for ongoing management may sometimes differ from that of the smear taker who holds the full clinical history and examination results of a participating woman, particularly if a woman has been treated overseas. Therefore it is necessary from time to time to update a woman’s screening history as held on the Register and so avoid inappropriate letters being sent by the Programme to a participating woman.
To receive the Screening Matters newsletter by email, fill out our sign-up form.